Clinical Trials
2 trialsNCT05223088 2025-03-18
Tislelizumab Combined With Apatinib and Oxaliplatin Plus S1 as Neoadjuvant Therapy for Borrmann IVăLarge Borrmann III Type and Bulky N Positive Advanced Gastric Cancer
Fujian Cancer Hospital
Phase 2 Completed
NCT01037998 2009-12-23
UFUR (Tegafur/Uracil) Plus Iressa in Non-small-cell Lung Cancer
Taipei Veterans General Hospital, Taiwan
Phase 2 Completed